Related Experiment Video
Updated: Feb 14, 2026

Mouse Model of Pressure Ulcers After Spinal Cord Injury
Published on: March 9, 2019
Bacteremia associated with pressure ulcers: a prospective cohort study
Elena Espejo1, Marta Andrés2, Rosa-Maria Borrallo3
1Infectious Diseases Unit, Internal Medicine Service, Hospital de Terrassa (Consorci Sanitari de Terrassa), Ctra. Torrebonica s/n, 08227, Terrassa, Spain. 12088eea@comb.cat.
Bacteremia associated with pressure ulcers (BAPU) is uncommon but has a high mortality rate. Risk factors include hospital-acquired infections, polymicrobial bacteremia, and low serum albumin levels. Incidence has declined with multidisciplinary care.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Geriatrics
Background:
- Pressure ulcers are a significant concern in healthcare settings, potentially leading to severe complications.
- Bacteremia associated with pressure ulcers (BAPU) represents a serious clinical challenge with high morbidity and mortality.
- Understanding the epidemiology and risk factors for BAPU is crucial for effective patient management.
Purpose of the Study:
- To investigate the clinical and microbiological features of BAPU.
- To identify factors associated with mortality in patients with BAPU.
- To analyze trends in BAPU incidence over time.
Main Methods:
- Prospective observational cohort study conducted over a long period (1984-2015) at a teaching hospital.
- Inclusion of 56 episodes of BAPU.
- Statistical analysis to determine risk factors for mortality, including odds ratios and confidence intervals.
Main Results:
- The incidence of BAPU significantly decreased over the study period.
- Common causative microorganisms included Staphylococcus aureus, Proteus spp., and Bacteroides spp.
- Overall mortality was 41.1%, with independent risk factors being hospital-acquired bacteremia, polymicrobial bacteremia, and low serum albumin (<23 g/L).
Conclusions:
- BAPU is an infrequent but severe complication of pressure ulcers.
- The decline in BAPU incidence suggests the effectiveness of multidisciplinary teams in ulcer management.
- Prompt identification and management of risk factors are essential to reduce mortality associated with BAPU.
More Related Videos
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Vapor Pressure
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Definition and Measurement of Pressure: Atmospheric Pressure, Barometer, and Manometer